Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 2/20 | 0.56 |
| ▸ | LPL | P06858 | 3/20 | 0.45 |
| ▸ | LIPG | Q9Y5X9 | 3/20 | 0.45 |
| ▸ | ENPP2 | Q13822 | 8/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | CA6 | P23280 | 1/20 | 0.37 |
| ▸ | CA5A | P35218 | 1/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.37 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28786300 | 0.87 | CYP2C19 (0.53) | MGLLLPLLIPGENPP2KDM4E | |
| SCHEMBL19663724 | 0.85 | MGLL (0.56) | MGLLLPLLIPGENPP2KDM4E | |
| SCHEMBL840219 | 0.80 | MGLL (0.64) | MGLLLPLLIPGENPP2KDM4E | |
| SCHEMBL1814249 | 0.79 | MGLL (0.62) | MGLLLPLLIPGENPP2KDM4E | |
| SCHEMBL16307074 | 0.78 | MGLL (0.56) | MGLLLPLLIPGENPP2KDM4E | |
| SCHEMBL2030291 | 0.77 | MGLL (0.71) | MGLLLPLLIPGENPP2KDM4E | |
| SCHEMBL16550399 | 0.76 | LPL (0.50) | MGLLLPLLIPGENPP2CA1 | |
| SCHEMBL28786301 | 0.76 | MGLL (0.50) | MGLLLPLLIPGENPP2KDM4E | |
| SCHEMBL19663684 | 0.75 | MGLL (0.45) | MGLLLPLLIPGENPP2KDM4E | |
| SCHEMBL14395956 | 0.75 | KCNN4 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10689404-B1 | Preparation method of tetraboronic acid compounds, and tetraboronic acid compounds | TAMKANG UNIVERSITY (TW) | 2020-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10689404-B1 | Preparation method of tetraboronic acid compounds, and tetraboronic acid compounds | TBCB, F7, ACAD9 | MGLL 2128/4885LPL 3907/4885LIPG 3720/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.